A Phase I/II Trial Testing Nelfinavir, an Inhibitor of Akt Signaling, in Combination With Preoperative Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 04 May 2013
At a glance
- Drugs Nelfinavir (Primary) ; Capecitabine
- Indications Rectal cancer
- Focus Adverse reactions; Therapeutic Use
- 04 May 2013 Planned number of patients changed from 55 to 61 as reported by European Clinical Trials Database.
- 04 May 2013 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
- 07 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.